PharmaTimes - April 2024

Blockbusters

The unseemly public health blockage is a symptom of communal constipation that is not shifting.

The distribution of pharmaceuticals through the traditional means is abjectly failing as a result. And the truth that dare not speak its name, is that no amount of money will solve it – you may as well toss Maltesers into an active volcano.

The treatment of this enduring conundrum, however, is eminently solvable.

Indeed, for as long as anyone can remember the solution has always been there. On every street corner, they are instantly recognisable and a stone’s throw from everywhere.

No, I’m not talking about Greggs. I’m referring to the humble pharmacy – criminally underused for hundreds of years, totally misunderstood for more.

Having written about this very subject for many years and spoken to a great many pharmacists, the frustration has persisted.

The most commonly used expression in terms of how pharmacists are typically perceived comes from these highly qualifed health professionals themselves – ‘people think we’re just Smartie counters’ (and variations on this confectionary/arithmetic-based theme).

Now, mercifully, these quietly efcient, pragmatic, knowledgeable and community immersed individuals are able to properly engage with patients, testing them, undertaking procedures and – critically – prescribing some drugs.

It has taken a full-on crisis across the NHS, but pharmacists are fnally being ordained. They are stepping out of the shadows, not as a middle person, but as a vital decision-maker.

It’s not just the road to Damascus, but the street, avenue, shopping mall and retail park to, erm, Damascus.

That’s blockbusters! Enjoy the magazine

April 2024 - magazine highlights

Dynamic digital age

Using integration frameworks to realise big data’s potenti...

Human league

Transforming market access through patient perspectives

Zero to hero?

Scope 3 emissions – a strategic imperative for pharma

Dutch courage

The EPA 2024 – How was this intriguing event for you?

Digital destiny

Sustaining digital products across pharma organisations

The phorce is with us

Pharmacy is finally getting new clinically based services

Marking time

Growth of biomarkers in lung cancer drug development

Getting to the point

Revolutionising pharma trials – AI and data’s growing infl...